25 XP   0   0   10

Eris Lifesciences Limited
Buy, Hold or Sell?

Let's analyse Eris together

PenkeI guess you are interested in Eris Lifesciences Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Eris Lifesciences Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Eris Lifesciences Limited

I send you an email if I find something interesting about Eris Lifesciences Limited.

Quick analysis of Eris (30 sec.)










What can you expect buying and holding a share of Eris? (30 sec.)

How much money do you get?

How much money do you get?
INR0.35
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR163.08
Expected worth in 1 year
INR254.38
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR120.64
Return On Investment
13.9%

For what price can you sell your share?

Current Price per Share
INR870.10
Expected price per share
INR824.30 - INR962.90
How sure are you?
50%

1. Valuation of Eris (5 min.)




Live pricePrice per Share (EOD)

INR870.10

Intrinsic Value Per Share

INR-594.50 - INR-132.21

Total Value Per Share

INR-431.42 - INR30.88

2. Growth of Eris (5 min.)




Is Eris growing?

Current yearPrevious yearGrowGrow %
How rich?$266.4m$228.9m$37.4m14.1%

How much money is Eris making?

Current yearPrevious yearGrowGrow %
Making money$45.8m$48.7m-$2.8m-6.3%
Net Profit Margin23.0%30.6%--

How much money comes from the company's main activities?

3. Financial Health of Eris (5 min.)




What can you expect buying and holding a share of Eris? (5 min.)

Welcome investor! Eris's management wants to use your money to grow the business. In return you get a share of Eris.

What can you expect buying and holding a share of Eris?

First you should know what it really means to hold a share of Eris. And how you can make/lose money.

Speculation

The Price per Share of Eris is INR870.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Eris.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Eris, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR163.08. Based on the TTM, the Book Value Change Per Share is INR22.82 per quarter. Based on the YOY, the Book Value Change Per Share is INR24.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR7.34 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Eris.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.340.0%0.340.0%0.360.0%0.300.0%0.220.0%
Usd Book Value Change Per Share0.270.0%0.270.0%0.290.0%0.240.0%0.190.0%
Usd Dividend Per Share0.090.0%0.090.0%0.070.0%0.060.0%0.060.0%
Usd Total Gains Per Share0.360.0%0.360.0%0.360.0%0.300.0%0.240.0%
Usd Price Per Share6.87-6.87-8.26-6.91-4.42-
Price to Earnings Ratio20.38-20.38-23.07-22.85-15.16-
Price-to-Total Gains Ratio18.97-18.97-22.66-23.93-24.70-
Price to Book Ratio3.51-3.51-4.91-5.03-3.76-
Price-to-Total Gains Ratio18.97-18.97-22.66-23.93-24.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.4412
Number of shares95
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.090.06
Usd Book Value Change Per Share0.270.24
Usd Total Gains Per Share0.360.30
Gains per Quarter (95 shares)34.3828.34
Gains per Year (95 shares)137.53113.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1331041282390103
26720826647180216
310031240470270329
413441654294360442
5167520680117450555
6201624818140540668
7234729956164630781
82688331094187720894
930193712322118101007
10335104113702349001120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.01.091.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.01.091.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%

Fundamentals of Eris

About Eris Lifesciences Limited

Eris Lifesciences Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti"diabetes, anti-infective, blood related, cardiovascular, dermatology, gastrointestinal, gastroenterology, haematinics, hormones, nero/ central nervous system, neuropsychiatry, otologicals, pain/analgesics, respiratory, stomatologicals, cosmetology, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. The company offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Fundamental data was last updated by Penke on 2024-04-21 10:25:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Eris Lifesciences Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Eris earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 23.0% means that ₹0.23 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Eris Lifesciences Limited:

  • The MRQ is 23.0%. The company is making a huge profit. +2
  • The TTM is 23.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.0%TTM23.0%0.0%
TTM23.0%YOY30.6%-7.6%
TTM23.0%5Y28.4%-5.4%
5Y28.4%10Y26.2%+2.2%
1.1.2. Return on Assets

Shows how efficient Eris is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.4% Return on Assets means that Eris generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Eris Lifesciences Limited:

  • The MRQ is 10.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.4%TTM10.4%0.0%
TTM10.4%YOY17.9%-7.5%
TTM10.4%5Y17.2%-6.7%
5Y17.2%10Y22.7%-5.5%
1.1.3. Return on Equity

Shows how efficient Eris is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • 17.4% Return on Equity means Eris generated ₹0.17 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Eris Lifesciences Limited:

  • The MRQ is 17.4%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 17.4%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.4%TTM17.4%0.0%
TTM17.4%YOY21.3%-3.9%
TTM17.4%5Y22.0%-4.6%
5Y22.0%10Y30.4%-8.4%

1.2. Operating Efficiency of Eris Lifesciences Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Eris is operating .

  • Measures how much profit Eris makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 25.9% means the company generated ₹0.26  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Eris Lifesciences Limited:

  • The MRQ is 25.9%. The company is operating very efficient. +2
  • The TTM is 25.9%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ25.9%TTM25.9%0.0%
TTM25.9%YOY32.6%-6.7%
TTM25.9%5Y31.0%-5.0%
5Y31.0%10Y29.4%+1.6%
1.2.2. Operating Ratio

Measures how efficient Eris is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.75 means that the operating costs are ₹0.75 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Eris Lifesciences Limited:

  • The MRQ is 0.747. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.747. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.747TTM0.7470.000
TTM0.747YOY0.679+0.068
TTM0.7475Y0.695+0.053
5Y0.69510Y0.715-0.020

1.3. Liquidity of Eris Lifesciences Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Eris is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.73 means the company has ₹1.73 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Eris Lifesciences Limited:

  • The MRQ is 1.725. The company is able to pay all its short-term debts. +1
  • The TTM is 1.725. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.725TTM1.7250.000
TTM1.725YOY3.142-1.417
TTM1.7255Y2.496-0.771
5Y2.49610Y2.584-0.088
1.3.2. Quick Ratio

Measures if Eris is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.95 means the company can pay off ₹0.95 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Eris Lifesciences Limited:

  • The MRQ is 0.946. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.946. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.946TTM0.9460.000
TTM0.946YOY2.654-1.708
TTM0.9465Y2.122-1.176
5Y2.12210Y2.686-0.564

1.4. Solvency of Eris Lifesciences Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Eris assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Eris to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.39 means that Eris assets are financed with 39.4% credit (debt) and the remaining percentage (100% - 39.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Eris Lifesciences Limited:

  • The MRQ is 0.394. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.394. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.394TTM0.3940.000
TTM0.394YOY0.160+0.234
TTM0.3945Y0.222+0.173
5Y0.22210Y0.246-0.025
1.4.2. Debt to Equity Ratio

Measures if Eris is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 65.9% means that company has ₹0.66 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Eris Lifesciences Limited:

  • The MRQ is 0.659. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.659. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.659TTM0.6590.000
TTM0.659YOY0.191+0.468
TTM0.6595Y0.309+0.350
5Y0.30910Y0.353-0.044

2. Market Valuation of Eris Lifesciences Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Eris generates.

  • Above 15 is considered overpriced but always compare Eris to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 20.38 means the investor is paying ₹20.38 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Eris Lifesciences Limited:

  • The EOD is 31.003. Based on the earnings, the company is overpriced. -1
  • The MRQ is 20.385. Based on the earnings, the company is fair priced.
  • The TTM is 20.385. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD31.003MRQ20.385+10.618
MRQ20.385TTM20.3850.000
TTM20.385YOY23.071-2.687
TTM20.3855Y22.848-2.464
5Y22.84810Y15.163+7.685
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Eris Lifesciences Limited:

  • The EOD is -21.554. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.172. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -14.172. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.554MRQ-14.172-7.382
MRQ-14.172TTM-14.1720.000
TTM-14.172YOY36.425-50.597
TTM-14.1725Y27.210-41.382
5Y27.21010Y18.853+8.357
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Eris is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 3.51 means the investor is paying ₹3.51 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Eris Lifesciences Limited:

  • The EOD is 5.335. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.508. Based on the equity, the company is fair priced.
  • The TTM is 3.508. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.335MRQ3.508+1.827
MRQ3.508TTM3.5080.000
TTM3.508YOY4.910-1.402
TTM3.5085Y5.028-1.520
5Y5.02810Y3.755+1.273
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Eris Lifesciences Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--22.82322.8230%24.387-6%19.730+16%15.502+47%
Book Value Per Share--163.083163.0830%140.261+16%119.710+36%75.858+115%
Current Ratio--1.7251.7250%3.142-45%2.496-31%2.584-33%
Debt To Asset Ratio--0.3940.3940%0.160+146%0.222+78%0.246+60%
Debt To Equity Ratio--0.6590.6590%0.191+245%0.309+113%0.353+87%
Dividend Per Share--7.3377.3370%6.000+22%5.132+43%4.785+53%
Eps--28.06528.0650%29.851-6%25.348+11%18.578+51%
Free Cash Flow Per Share---40.368-40.3680%18.908-314%5.281-864%6.874-687%
Free Cash Flow To Equity Per Share--10.16010.1600%15.622-35%5.432+87%8.797+15%
Gross Profit Margin--0.6360.6360%0.750-15%0.6380%0.492+29%
Intrinsic Value_10Y_max---132.206--------
Intrinsic Value_10Y_min---594.499--------
Intrinsic Value_1Y_max--2.542--------
Intrinsic Value_1Y_min---14.107--------
Intrinsic Value_3Y_max---4.397--------
Intrinsic Value_3Y_min---82.015--------
Intrinsic Value_5Y_max---25.843--------
Intrinsic Value_5Y_min---192.837--------
Market Cap118374501660.800+34%77901775158.90077901775158.9000%93695574409.600-17%78664579569.540-1%50328852284.770+55%
Net Profit Margin--0.2300.2300%0.306-25%0.284-19%0.262-12%
Operating Margin--0.2590.2590%0.326-20%0.310-16%0.294-12%
Operating Ratio--0.7470.7470%0.679+10%0.695+8%0.715+5%
Pb Ratio5.335+34%3.5083.5080%4.910-29%5.028-30%3.755-7%
Pe Ratio31.003+34%20.38520.3850%23.071-12%22.848-11%15.163+34%
Price Per Share870.100+34%572.100572.1000%688.700-17%575.920-1%367.935+55%
Price To Free Cash Flow Ratio-21.554-52%-14.172-14.1720%36.425-139%27.210-152%18.853-175%
Price To Total Gains Ratio28.849+34%18.96918.9690%22.664-16%23.925-21%24.698-23%
Quick Ratio--0.9460.9460%2.654-64%2.122-55%2.686-65%
Return On Assets--0.1040.1040%0.179-42%0.172-39%0.227-54%
Return On Equity--0.1740.1740%0.213-18%0.220-21%0.304-43%
Total Gains Per Share--30.16030.1600%30.387-1%24.862+21%20.287+49%
Usd Book Value--266481240.000266481240.0000%228984360.000+16%196091136.000+36%124450236.000+114%
Usd Book Value Change Per Share--0.2740.2740%0.293-6%0.237+16%0.186+47%
Usd Book Value Per Share--1.9571.9570%1.683+16%1.437+36%0.910+115%
Usd Dividend Per Share--0.0880.0880%0.072+22%0.062+43%0.057+53%
Usd Eps--0.3370.3370%0.358-6%0.304+11%0.223+51%
Usd Free Cash Flow---65961960.000-65961960.0000%30867720.000-314%8687232.000-859%11329524.000-682%
Usd Free Cash Flow Per Share---0.484-0.4840%0.227-314%0.063-864%0.082-687%
Usd Free Cash Flow To Equity Per Share--0.1220.1220%0.187-35%0.065+87%0.106+15%
Usd Market Cap1420494019.930+34%934821301.907934821301.9070%1124346892.915-17%943974954.834-1%603946227.417+55%
Usd Price Per Share10.441+34%6.8656.8650%8.264-17%6.911-1%4.415+55%
Usd Profit--45858960.00045858960.0000%48733560.000-6%41673600.000+10%30789672.000+49%
Usd Revenue--199417920.000199417920.0000%159140160.000+25%148944312.000+34%113255700.000+76%
Usd Total Gains Per Share--0.3620.3620%0.365-1%0.298+21%0.243+49%
 EOD+5 -3MRQTTM+0 -0YOY+10 -265Y+19 -1710Y+21 -15

3.2. Fundamental Score

Let's check the fundamental score of Eris Lifesciences Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1531.003
Price to Book Ratio (EOD)Between0-15.335
Net Profit Margin (MRQ)Greater than00.230
Operating Margin (MRQ)Greater than00.259
Quick Ratio (MRQ)Greater than10.946
Current Ratio (MRQ)Greater than11.725
Debt to Asset Ratio (MRQ)Less than10.394
Debt to Equity Ratio (MRQ)Less than10.659
Return on Equity (MRQ)Greater than0.150.174
Return on Assets (MRQ)Greater than0.050.104
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Eris Lifesciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.056
Ma 20Greater thanMa 50854.538
Ma 50Greater thanMa 100867.862
Ma 100Greater thanMa 200885.148
OpenGreater thanClose883.500
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
Total Other Income Expense Net 64,06030,92094,980-26,10068,880108,060176,940-347,140-170,200



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets36,673,280
Total Liabilities14,466,510
Total Stockholder Equity21,959,880
 As reported
Total Liabilities 14,466,510
Total Stockholder Equity+ 21,959,880
Total Assets = 36,673,280

Assets

Total Assets36,673,280
Total Current Assets7,647,220
Long-term Assets29,026,060
Total Current Assets
Cash And Cash Equivalents 560,220
Short-term Investments 332,210
Net Receivables 2,966,950
Inventory 1,314,350
Other Current Assets 2,473,490
Total Current Assets  (as reported)7,647,220
Total Current Assets  (calculated)7,647,220
+/-0
Long-term Assets
Property Plant Equipment 3,773,790
Goodwill 3,318,490
Intangible Assets 18,805,960
Other Assets 2,929,240
Long-term Assets  (as reported)29,026,060
Long-term Assets  (calculated)28,827,480
+/- 198,580

Liabilities & Shareholders' Equity

Total Current Liabilities4,432,330
Long-term Liabilities10,034,180
Total Stockholder Equity21,959,880
Total Current Liabilities
Short-term Debt 1,932,900
Short Long Term Debt 1,855,690
Accounts payable 1,247,690
Other Current Liabilities 217,220
Total Current Liabilities  (as reported)4,432,330
Total Current Liabilities  (calculated)5,253,500
+/- 821,170
Long-term Liabilities
Long term Debt Total 6,834,210
Long term Debt 6,444,470
Capital Lease Obligations Min Short Term Debt-1,465,950
Long-term Liabilities Other 113,220
Long-term Liabilities  (as reported)10,034,180
Long-term Liabilities  (calculated)11,925,950
+/- 1,891,770
Total Stockholder Equity
Common Stock135,990
Retained Earnings 21,559,300
Accumulated Other Comprehensive Income 29,760
Capital Surplus 151,010
Total Stockholder Equity (as reported)21,959,880
Total Stockholder Equity (calculated)21,876,060
+/- 83,820
Other
Capital Stock135,990
Cash and Short Term Investments 892,430
Common Stock Shares Outstanding 136,168
Current Deferred Revenue1,034,520
Liabilities and Stockholders Equity 36,673,280
Net Debt 8,206,890
Net Invested Capital 30,260,040
Net Working Capital 3,214,890
Property Plant and Equipment Gross 3,773,790
Short Long Term Debt Total 8,767,110



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-31
> Total Assets 
1,019,670
1,718,050
2,705,990
3,572,850
4,185,780
6,409,970
14,600,850
15,536,620
15,523,050
18,347,800
22,721,390
36,673,280
36,673,28022,721,39018,347,80015,523,05015,536,62014,600,8506,409,9704,185,7803,572,8502,705,9901,718,0501,019,670
   > Total Current Assets 
0
1,263,550
1,554,780
1,634,780
1,592,900
3,844,770
2,987,070
5,817,790
4,796,170
4,670,460
6,273,300
7,647,220
7,647,2206,273,3004,670,4604,796,1705,817,7902,987,0703,844,7701,592,9001,634,7801,554,7801,263,5500
       Cash And Cash Equivalents 
93,260
48,970
72,850
57,210
88,680
24,210
106,080
75,000
672,110
368,700
507,940
560,220
560,220507,940368,700672,11075,000106,08024,21088,68057,21072,85048,97093,260
       Short-term Investments 
134,520
465,000
669,640
692,400
653,200
2,584,830
937,890
3,149,420
747,810
153,990
1,264,470
332,210
332,2101,264,470153,990747,8103,149,420937,8902,584,830653,200692,400669,640465,000134,520
       Net Receivables 
150,280
176,150
253,900
259,580
253,700
558,630
1,083,880
1,760,370
2,076,450
2,280,610
2,260,930
2,966,950
2,966,9502,260,9302,280,6102,076,4501,760,3701,083,880558,630253,700259,580253,900176,150150,280
       Other Current Assets 
89,430
317,600
364,180
309,120
374,810
677,530
1,288,620
6,470
2,681,500
922,500
1,060,850
2,473,490
2,473,4901,060,850922,5002,681,5006,4701,288,620677,530374,810309,120364,180317,60089,430
   > Long-term Assets 
0
454,500
1,151,210
1,938,070
2,592,880
2,565,200
11,613,780
9,718,830
10,726,880
13,677,340
16,448,090
29,026,060
29,026,06016,448,09013,677,34010,726,8809,718,83011,613,7802,565,2002,592,8801,938,0701,151,210454,5000
       Property Plant Equipment 
198,230
235,170
710,510
674,990
706,660
553,860
526,120
560,710
872,430
778,780
1,918,570
3,773,790
3,773,7901,918,570778,780872,430560,710526,120553,860706,660674,990710,510235,170198,230
       Goodwill 
32,970
32,840
32,160
35,530
0
792,610
1,869,480
935,870
934,740
934,740
934,740
3,318,490
3,318,490934,740934,740934,740935,8701,869,480792,610035,53032,16032,84032,970
       Long Term Investments 
0
0
170,020
972,770
625,970
2,130,520
2,716,100
409,120
0
0
0
0
0000409,1202,716,1002,130,520625,970972,770170,02000
       Intangible Assets 
33,610
820
6,580
6,900
6,950
363,340
6,250,070
6,136,080
6,984,690
6,840,760
6,595,980
18,805,960
18,805,9606,595,9806,840,7606,984,6906,136,0806,250,070363,3406,9506,9006,58082033,610
       Long-term Assets Other 
0
647,980
899,440
907,190
802,010
3,244,100
184,230
3,378,530
193,870
257,590
359,020
319,600
319,600359,020257,590193,8703,378,530184,2303,244,100802,010907,190899,440647,9800
> Total Liabilities 
490,690
609,720
897,400
876,950
945,340
1,010,730
5,741,130
3,848,350
2,559,710
2,583,570
3,639,360
14,466,510
14,466,5103,639,3602,583,5702,559,7103,848,3505,741,1301,010,730945,340876,950897,400609,720490,690
   > Total Current Liabilities 
352,820
435,560
716,460
658,710
689,510
758,190
2,254,600
3,055,370
1,646,900
1,669,310
1,996,460
4,432,330
4,432,3301,996,4601,669,3101,646,9003,055,3702,254,600758,190689,510658,710716,460435,560352,820
       Short-term Debt 
0
62,200
79,360
28,560
5,000
72,650
1,026,040
1,761,300
59,990
23,300
40,130
1,932,900
1,932,90040,13023,30059,9901,761,3001,026,04072,6505,00028,56079,36062,2000
       Short Long Term Debt 
0
0
79,360
5,000
5,000
72,650
1,026,040
1,761,300
0
100
110
1,855,690
1,855,69011010001,761,3001,026,04072,6505,0005,00079,36000
       Accounts payable 
180,920
220,170
373,830
367,110
245,660
385,170
907,740
841,250
1,000,510
1,026,160
1,177,740
1,247,690
1,247,6901,177,7401,026,1601,000,510841,250907,740385,170245,660367,110373,830220,170180,920
       Other Current Liabilities 
140,100
153,190
263,270
263,040
514,030
300,370
1,202,990
434,710
162,080
132,460
152,370
217,220
217,220152,370132,460162,080434,7101,202,990300,370514,030263,040263,270153,190140,100
   > Long-term Liabilities 
0
174,160
180,940
218,240
255,830
252,540
3,486,530
792,980
912,810
914,260
1,642,900
10,034,180
10,034,1801,642,900914,260912,810792,9803,486,530252,540255,830218,240180,940174,1600
       Long term Debt Total 
0
0
0
0
0
4,940
2,741,950
2,930
61,440
44,470
803,940
6,834,210
6,834,210803,94044,47061,4402,9302,741,9504,94000000
       Capital Lease Obligations Min Short Term Debt
0
-62,200
-79,360
-28,560
-5,000
-72,650
-1,026,040
-1,761,300
61,440
44,370
353,830
-1,465,950
-1,465,950353,83044,37061,440-1,761,300-1,026,040-72,650-5,000-28,560-79,360-62,2000
       Long-term Liabilities Other 
0
0
0
0
0
36,070
12,160
55,730
31,070
24,920
22,820
113,220
113,22022,82024,92031,07055,73012,16036,07000000
> Total Stockholder Equity
478,900
1,060,850
1,765,040
2,656,660
3,208,420
5,399,240
8,613,070
11,505,160
12,963,340
15,764,210
19,083,110
21,959,880
21,959,88019,083,11015,764,21012,963,34011,505,1608,613,0705,399,2403,208,4202,656,6601,765,0401,060,850478,900
   Common Stock
1,380
1,380
1,380
1,380
1,380
137,500
137,500
137,500
135,780
135,780
135,930
135,990
135,990135,930135,780135,780137,500137,500137,5001,3801,3801,3801,3801,380
   Retained Earnings 
477,520
1,052,470
1,756,660
2,648,280
3,200,040
5,254,740
8,468,570
11,335,220
12,797,280
15,503,130
18,736,530
21,559,300
21,559,30018,736,53015,503,13012,797,28011,335,2208,468,5705,254,7403,200,0402,648,2801,756,6601,052,470477,520
   Capital Surplus 
0
0
0
0
0
0
0
13,490
0
0
106,130
151,010
151,010106,1300013,4900000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
125,040
170,280
322,350
7,000
626,960
396,870
576,430
-12,849,240
-15,638,910
-18,872,460
-21,695,290
-21,695,290-18,872,460-15,638,910-12,849,240576,430396,870626,9607,000322,350170,280125,0400



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue16,618,160
Cost of Revenue-3,523,500
Gross Profit13,094,66013,094,660
 
Operating Income (+$)
Gross Profit13,094,660
Operating Expense-8,898,080
Operating Income4,216,6304,196,580
 
Operating Expense (+$)
Research Development61,000
Selling General Administrative471,750
Selling And Marketing Expenses1,390,020
Operating Expense8,898,0801,922,770
 
Net Interest Income (+$)
Interest Income261,680
Interest Expense-261,680
Other Finance Cost-261,680
Net Interest Income-261,680
 
Pretax Income (+$)
Operating Income4,216,630
Net Interest Income-261,680
Other Non-Operating Income Expenses0
Income Before Tax (EBT)4,046,4304,386,830
EBIT - interestExpense = 4,046,430
4,126,410
4,083,260
Interest Expense261,680
Earnings Before Interest and Taxes (EBIT)4,308,1104,308,110
Earnings Before Interest and Taxes (EBITDA)5,478,990
 
After tax Income (+$)
Income Before Tax4,046,430
Tax Provision-304,830
Net Income From Continuing Ops3,741,6003,741,600
Net Income3,821,580
Net Income Applicable To Common Shares3,821,580
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses12,421,580
Total Other Income/Expenses Net-170,200261,680
 

Technical Analysis of Eris
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Eris. The general trend of Eris is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Eris's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Eris Lifesciences Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 934.55 < 962.20 < 962.90.

The bearish price targets are: 862.15 > 832.00 > 824.30.

Tweet this
Eris Lifesciences Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Eris Lifesciences Limited. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Eris Lifesciences Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Eris Lifesciences Limited. The current macd is 3.07050167.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Eris price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Eris. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Eris price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Eris Lifesciences Limited Daily Moving Average Convergence/Divergence (MACD) ChartEris Lifesciences Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Eris Lifesciences Limited. The current adx is 12.71.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Eris shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Eris Lifesciences Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Eris Lifesciences Limited. The current sar is 810.85.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Eris Lifesciences Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Eris Lifesciences Limited. The current rsi is 54.06. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Eris Lifesciences Limited Daily Relative Strength Index (RSI) ChartEris Lifesciences Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Eris Lifesciences Limited. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Eris price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Eris Lifesciences Limited Daily Stochastic Oscillator ChartEris Lifesciences Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Eris Lifesciences Limited. The current cci is 126.68.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Eris Lifesciences Limited Daily Commodity Channel Index (CCI) ChartEris Lifesciences Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Eris Lifesciences Limited. The current cmo is 13.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Eris Lifesciences Limited Daily Chande Momentum Oscillator (CMO) ChartEris Lifesciences Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Eris Lifesciences Limited. The current willr is -34.28981349.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Eris is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Eris Lifesciences Limited Daily Williams %R ChartEris Lifesciences Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Eris Lifesciences Limited.

Eris Lifesciences Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Eris Lifesciences Limited. The current atr is 21.87.

Eris Lifesciences Limited Daily Average True Range (ATR) ChartEris Lifesciences Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Eris Lifesciences Limited. The current obv is 8,619,700.

Eris Lifesciences Limited Daily On-Balance Volume (OBV) ChartEris Lifesciences Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Eris Lifesciences Limited. The current mfi is 53.30.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Eris Lifesciences Limited Daily Money Flow Index (MFI) ChartEris Lifesciences Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Eris Lifesciences Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Eris Lifesciences Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Eris Lifesciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.056
Ma 20Greater thanMa 50854.538
Ma 50Greater thanMa 100867.862
Ma 100Greater thanMa 200885.148
OpenGreater thanClose883.500
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Eris with someone you think should read this too:
  • Are you bullish or bearish on Eris? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Eris? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Eris Lifesciences Limited

I send you an email if I find something interesting about Eris Lifesciences Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Eris Lifesciences Limited.

Receive notifications about Eris Lifesciences Limited in your mailbox!